Davies S L, Moral M A
Drug News Perspect. 2006 Nov;19(9):572-3.
This month's Spotlight on... focuses on the current clinical development of the antiepileptic drug levetiracetam for amyotrophic lateral sclerosis. We highlight the experimental rationale behind its progress into patient cohorts with regards to targeting three currently untreatable aspects of human amyotrophic lateral sclerosis: cramps, spasticity and disease progression.
本月的“聚焦……”专栏重点关注抗癫痫药物左乙拉西坦用于肌萎缩侧索硬化症的当前临床进展。我们着重介绍了其在患者群体中开展研究的实验依据,该研究旨在针对人类肌萎缩侧索硬化症目前三个无法治疗的方面:痉挛、肌张力障碍和疾病进展。